Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Hospital operator HCA raises 2023 profit view as surgery volumes rebound

Published 07/27/2023, 07:45 AM
Updated 07/27/2023, 09:16 AM
© Reuters. FILE PHOTO: HCA Healthcare Inc logo is seen displayed in this illustration taken April 10, 2023. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) -Hospital operator HCA Healthcare (NYSE:HCA) Inc on Thursday raised its annual profit forecast, betting on a recovery in non-urgent medical procedures as more patients return to hospitals for surgeries delayed during the COVID-19 pandemic.

The volumes of medical procedures are trending upwards after the U.S. government ended the public health emergency status for COVID-19 in May.

The demand recovery has also boosted margins for others including medical device makers such as Johnson & Johnson (NYSE:JNJ) and Abbott Laboratories (NYSE:ABT), which topped second-quarter profit estimates last week.

HCA raised its full year profit forecast in the range of $17.70 to $18.90 per share, up from $17.25 to $18.55 previously.

Some insurers have, however, indicated that the recovery in medical procedures was not as per expectation, and the jump was mostly limited to hip and knee replacements among older adults.

UnitedHealth Group (NYSE:UNH) had warned earlier this year that a resumption in long-delayed surgical procedures would hit profit growth, but reported a smaller-than-expected jump in medical costs that allayed fears of rising costs.

© Reuters. FILE PHOTO: HCA Healthcare Inc logo is seen displayed in this illustration taken April 10, 2023. REUTERS/Dado Ruvic/Illustration/File Photo

Heightened expectations of a spike in surgical procedures ahead of the earnings could drive HCA stock lower on Thursday, said Citi analyst Jason Cassorla.

Shares of HCA fell 3.4% to $272.3 in premarket trading even as the company's second-quarter revenue of $15.86 billion beat Refinitiv estimates of $15.62 billion. The shares have risen 17% this year compared to a marginal decline in S&P 500 healthcare index.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.